June 20, 2017
Patheon NV's proposed $7.2 billion acquisition by Thermo Fisher leaves investors out to dry, they alleged Monday in a proposed class action in New York federal court accusing the company and directors of withholding key metrics and agreeing to unsatisfactory deal terms.